

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.99479229 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.99479229 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 5.58616362 |
| 4 | hemidesmosome assembly (GO:0031581) | 5.16636550 |
| 5 | skin morphogenesis (GO:0043589) | 4.75164280 |
| 6 | protein localization to endosome (GO:0036010) | 4.62138030 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.93969492 |
| 8 | mesodermal cell differentiation (GO:0048333) | 3.72107556 |
| 9 | substrate-dependent cell migration (GO:0006929) | 3.71037602 |
| 10 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.69741306 |
| 11 | COPII vesicle coating (GO:0048208) | 3.62976103 |
| 12 | endodermal cell differentiation (GO:0035987) | 3.61841964 |
| 13 | protein retention in ER lumen (GO:0006621) | 3.58342267 |
| 14 | cell-substrate junction assembly (GO:0007044) | 3.55420534 |
| 15 | wound healing, spreading of epidermal cells (GO:0035313) | 3.54009238 |
| 16 | hypotonic response (GO:0006971) | 3.49393495 |
| 17 | iron ion import (GO:0097286) | 3.44640045 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.31517945 |
| 19 | regulation of metalloenzyme activity (GO:0048552) | 3.29671179 |
| 20 | vesicle coating (GO:0006901) | 3.26885188 |
| 21 | mammary gland epithelial cell proliferation (GO:0033598) | 3.19423588 |
| 22 | membrane raft organization (GO:0031579) | 3.03262064 |
| 23 | nuclear pore complex assembly (GO:0051292) | 3.00316769 |
| 24 | cellular copper ion homeostasis (GO:0006878) | 2.98036610 |
| 25 | hyaluronan catabolic process (GO:0030214) | 2.97060680 |
| 26 | basement membrane organization (GO:0071711) | 2.96026807 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 2.94702620 |
| 28 | wound healing, spreading of cells (GO:0044319) | 2.89932298 |
| 29 | collagen fibril organization (GO:0030199) | 2.89261765 |
| 30 | response to peptidoglycan (GO:0032494) | 2.87667639 |
| 31 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.86744567 |
| 32 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85742319 |
| 33 | stress fiber assembly (GO:0043149) | 2.84893786 |
| 34 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.79438922 |
| 35 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.78872422 |
| 36 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.75828511 |
| 37 | embryonic process involved in female pregnancy (GO:0060136) | 2.74878307 |
| 38 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.68055938 |
| 39 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.68013012 |
| 40 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.67984057 |
| 41 | response to laminar fluid shear stress (GO:0034616) | 2.66576691 |
| 42 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.61412187 |
| 43 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.58385279 |
| 44 | barbed-end actin filament capping (GO:0051016) | 2.57726267 |
| 45 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.57480906 |
| 46 | decidualization (GO:0046697) | 2.57368141 |
| 47 | regulation of macrophage cytokine production (GO:0010935) | 2.56904821 |
| 48 | membrane protein ectodomain proteolysis (GO:0006509) | 2.55425003 |
| 49 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.54259804 |
| 50 | positive regulation of nuclease activity (GO:0032075) | 2.52841186 |
| 51 | activation of Rac GTPase activity (GO:0032863) | 2.50837286 |
| 52 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50214353 |
| 53 | natural killer cell mediated immunity (GO:0002228) | 2.49847368 |
| 54 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.49847368 |
| 55 | nuclear pore organization (GO:0006999) | 2.47511459 |
| 56 | protein hydroxylation (GO:0018126) | 2.47320581 |
| 57 | pore complex assembly (GO:0046931) | 2.46898844 |
| 58 | peptidyl-proline hydroxylation (GO:0019511) | 2.46414334 |
| 59 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.45369782 |
| 60 | negative regulation of anoikis (GO:2000811) | 2.44750839 |
| 61 | collagen metabolic process (GO:0032963) | 2.44381031 |
| 62 | oligosaccharide catabolic process (GO:0009313) | 2.44306864 |
| 63 | cellular response to vitamin D (GO:0071305) | 2.43591436 |
| 64 | sphingosine metabolic process (GO:0006670) | 2.42738602 |
| 65 | chondrocyte proliferation (GO:0035988) | 2.42217557 |
| 66 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41537513 |
| 67 | ER-nucleus signaling pathway (GO:0006984) | 2.39989726 |
| 68 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.39328381 |
| 69 | cellular response to unfolded protein (GO:0034620) | 2.38873967 |
| 70 | chondrocyte development (GO:0002063) | 2.37584623 |
| 71 | serine transport (GO:0032329) | 2.37195790 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.34851200 |
| 73 | regulation of nuclease activity (GO:0032069) | 2.34438331 |
| 74 | cellular response to arsenic-containing substance (GO:0071243) | 2.34027934 |
| 75 | apoptotic cell clearance (GO:0043277) | 2.32973214 |
| 76 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.32794051 |
| 77 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.32794051 |
| 78 | modulation by symbiont of host immune response (GO:0052553) | 2.32794051 |
| 79 | positive regulation by symbiont of host defense response (GO:0052509) | 2.32794051 |
| 80 | modulation by symbiont of host defense response (GO:0052031) | 2.32794051 |
| 81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.32794051 |
| 82 | extracellular matrix disassembly (GO:0022617) | 2.30371936 |
| 83 | positive regulation of interleukin-6 production (GO:0032755) | 2.28683454 |
| 84 | collagen catabolic process (GO:0030574) | 2.27911473 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26923024 |
| 86 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.26599724 |
| 87 | focal adhesion assembly (GO:0048041) | 2.26422090 |
| 88 | cell-substrate adherens junction assembly (GO:0007045) | 2.26422090 |
| 89 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.26176658 |
| 90 | cellular response to vitamin (GO:0071295) | 2.24628392 |
| 91 | protein maturation by protein folding (GO:0022417) | 2.23582454 |
| 92 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.23435119 |
| 93 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.23229058 |
| 94 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.23196730 |
| 95 | positive regulation of receptor recycling (GO:0001921) | 2.21946699 |
| 96 | response to vitamin D (GO:0033280) | 2.21704339 |
| 97 | cellular response to interferon-alpha (GO:0035457) | 2.21471278 |
| 98 | cellular protein complex localization (GO:0034629) | 2.21206935 |
| 99 | mitotic chromosome condensation (GO:0007076) | 2.20549431 |
| 100 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.19728051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.29437662 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.06481751 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.93135562 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.52556218 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.03032599 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.92511625 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.86039709 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.71851757 |
| 9 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.56713394 |
| 10 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.56713394 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.41815368 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39963426 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38584140 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31943574 |
| 15 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.23012415 |
| 16 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.21068618 |
| 17 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.16831230 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16661026 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16564610 |
| 20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.13128935 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11053809 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.06871200 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01052508 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.00627190 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.99881348 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97412517 |
| 27 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.96035816 |
| 28 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.88151849 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.88009719 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86008109 |
| 31 | ATF3_27146783_Chip-Seq_COLON_Human | 1.85418092 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.82858427 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78556578 |
| 34 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.77748239 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76622315 |
| 36 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.72421562 |
| 37 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67761210 |
| 38 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.66383932 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63627762 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.63371445 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60799638 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.56484242 |
| 43 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56312839 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55118984 |
| 45 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54962443 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52044798 |
| 47 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.50124326 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.48289732 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.47688099 |
| 50 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46757477 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44306697 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39423384 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37420456 |
| 54 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34029750 |
| 55 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.32113368 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31678172 |
| 57 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.31668082 |
| 58 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21000079 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20234780 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18451322 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18041796 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16331457 |
| 63 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14075811 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13506058 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12235389 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11821331 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11327788 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11170766 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11123494 |
| 70 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09255554 |
| 71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08966068 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08848447 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06750629 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06517170 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05902507 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05295107 |
| 77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05149931 |
| 78 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03461939 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01920112 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01353083 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00090425 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99989329 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98946107 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97869396 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96850185 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96598144 |
| 87 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95529263 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.94946158 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94711277 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93418448 |
| 91 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93063946 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92866564 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92547860 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91997046 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91640804 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90315141 |
| 97 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90003196 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88543167 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85978086 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84167485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.35835936 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.63408508 |
| 3 | MP0003566_abnormal_cell_adhesion | 3.19137237 |
| 4 | MP0004272_abnormal_basement_membrane | 3.12488383 |
| 5 | MP0005275_abnormal_skin_tensile | 2.58140616 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.57070302 |
| 7 | MP0003091_abnormal_cell_migration | 2.50366027 |
| 8 | MP0005451_abnormal_body_composition | 2.45576655 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.36085271 |
| 10 | MP0005623_abnormal_meninges_morphology | 2.21555706 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.21424163 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.12768178 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.05590943 |
| 14 | MP0002060_abnormal_skin_morphology | 2.04098991 |
| 15 | MP0003950_abnormal_plasma_membrane | 1.97971534 |
| 16 | MP0005058_abnormal_lysosome_morphology | 1.93523477 |
| 17 | MP0005023_abnormal_wound_healing | 1.90494604 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.87297218 |
| 19 | MP0003279_aneurysm | 1.86944383 |
| 20 | MP0009840_abnormal_foam_cell | 1.72111558 |
| 21 | MP0003941_abnormal_skin_development | 1.71182784 |
| 22 | MP0000858_altered_metastatic_potential | 1.66013245 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.56626089 |
| 24 | MP0006054_spinal_hemorrhage | 1.56161518 |
| 25 | MP0005164_abnormal_response_to | 1.53626962 |
| 26 | MP0008004_abnormal_stomach_pH | 1.51001218 |
| 27 | MP0005503_abnormal_tendon_morphology | 1.47959107 |
| 28 | MP0003828_pulmonary_edema | 1.47006798 |
| 29 | MP0008260_abnormal_autophagy | 1.43881309 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.43868626 |
| 31 | MP0004233_abnormal_muscle_weight | 1.40302555 |
| 32 | MP0001958_emphysema | 1.34742699 |
| 33 | MP0002896_abnormal_bone_mineralization | 1.33790654 |
| 34 | MP0005409_darkened_coat_color | 1.28519435 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.27859464 |
| 36 | MP0000343_altered_response_to | 1.25801040 |
| 37 | MP0003448_altered_tumor_morphology | 1.24350274 |
| 38 | MP0000767_abnormal_smooth_muscle | 1.23749206 |
| 39 | MP0003436_decreased_susceptibility_to | 1.18314555 |
| 40 | MP0001542_abnormal_bone_strength | 1.18296413 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.17234529 |
| 42 | MP0001216_abnormal_epidermal_layer | 1.15825309 |
| 43 | MP0004947_skin_inflammation | 1.14336319 |
| 44 | MP0009053_abnormal_anal_canal | 1.11963336 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.11660679 |
| 46 | MP0006082_CNS_inflammation | 1.10890869 |
| 47 | MP0001849_ear_inflammation | 1.10777071 |
| 48 | MP0005621_abnormal_cell_physiology | 1.10488946 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.07176150 |
| 50 | MP0001915_intracranial_hemorrhage | 1.06195105 |
| 51 | MP0001243_abnormal_dermal_layer | 1.05490754 |
| 52 | MP0002796_impaired_skin_barrier | 1.04181276 |
| 53 | MP0005165_increased_susceptibility_to | 1.04137410 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.03653690 |
| 55 | MP0000733_abnormal_muscle_development | 1.01818302 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.00780599 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 0.99628847 |
| 58 | MP0001533_abnormal_skeleton_physiology | 0.96382613 |
| 59 | MP0003075_altered_response_to | 0.95552051 |
| 60 | MP0004883_abnormal_blood_vessel | 0.92890284 |
| 61 | MP0005501_abnormal_skin_physiology | 0.91719772 |
| 62 | MP0004510_myositis | 0.90546747 |
| 63 | MP0002006_tumorigenesis | 0.90169522 |
| 64 | MP0005508_abnormal_skeleton_morphology | 0.90021667 |
| 65 | MP0000762_abnormal_tongue_morphology | 0.88278252 |
| 66 | MP0001348_abnormal_lacrimal_gland | 0.86243519 |
| 67 | MP0005390_skeleton_phenotype | 0.85726365 |
| 68 | MP0000627_abnormal_mammary_gland | 0.85542100 |
| 69 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84555376 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 0.83312325 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.82651102 |
| 72 | MP0008007_abnormal_cellular_replicative | 0.82259616 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.80042216 |
| 74 | MP0005384_cellular_phenotype | 0.79112339 |
| 75 | MP0003303_peritoneal_inflammation | 0.78138229 |
| 76 | MP0002419_abnormal_innate_immunity | 0.78067592 |
| 77 | MP0009785_altered_susceptibility_to | 0.77980303 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.77222155 |
| 79 | MP0000537_abnormal_urethra_morphology | 0.76971919 |
| 80 | MP0001835_abnormal_antigen_presentation | 0.76686171 |
| 81 | MP0000579_abnormal_nail_morphology | 0.73521153 |
| 82 | MP0008057_abnormal_DNA_replication | 0.73488633 |
| 83 | MP0005197_abnormal_uvea_morphology | 0.71968653 |
| 84 | MP0000358_abnormal_cell_content/ | 0.71057620 |
| 85 | MP0000371_diluted_coat_color | 0.69928733 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.68908930 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 0.68848466 |
| 88 | MP0010771_integument_phenotype | 0.68717489 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 0.68114913 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.67975439 |
| 91 | MP0004134_abnormal_chest_morphology | 0.67093698 |
| 92 | MP0003795_abnormal_bone_structure | 0.66928304 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.65757647 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.65753074 |
| 95 | MP0010307_abnormal_tumor_latency | 0.65349672 |
| 96 | MP0001881_abnormal_mammary_gland | 0.64989993 |
| 97 | MP0002269_muscular_atrophy | 0.64800412 |
| 98 | MP0000749_muscle_degeneration | 0.63200736 |
| 99 | MP0002113_abnormal_skeleton_development | 0.62487513 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.62016666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.52272795 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.59264425 |
| 3 | Atrophic scars (HP:0001075) | 3.81270847 |
| 4 | Arterial tortuosity (HP:0005116) | 3.49731187 |
| 5 | Vascular tortuosity (HP:0004948) | 3.47764104 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.40305536 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30546835 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30546835 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30546835 |
| 10 | Ankle contracture (HP:0006466) | 3.08897657 |
| 11 | Fragile skin (HP:0001030) | 3.08362687 |
| 12 | Aortic dissection (HP:0002647) | 3.01207957 |
| 13 | Wormian bones (HP:0002645) | 2.91613246 |
| 14 | Spinal rigidity (HP:0003306) | 2.91173109 |
| 15 | Spondylolisthesis (HP:0003302) | 2.88068018 |
| 16 | Follicular hyperkeratosis (HP:0007502) | 2.81130040 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 2.74074568 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.74074568 |
| 19 | Thoracolumbar scoliosis (HP:0002944) | 2.62633203 |
| 20 | Dilatation of the ascending aorta (HP:0005111) | 2.60846101 |
| 21 | Bladder diverticulum (HP:0000015) | 2.59098804 |
| 22 | Mitral stenosis (HP:0001718) | 2.58095902 |
| 23 | Cervical subluxation (HP:0003308) | 2.54977977 |
| 24 | Aortic aneurysm (HP:0004942) | 2.52103187 |
| 25 | Short nail (HP:0001799) | 2.51336189 |
| 26 | Genu recurvatum (HP:0002816) | 2.49449016 |
| 27 | Ankyloglossia (HP:0010296) | 2.48636615 |
| 28 | Milia (HP:0001056) | 2.44513000 |
| 29 | Elbow flexion contracture (HP:0002987) | 2.43339254 |
| 30 | Spinal cord lesions (HP:0100561) | 2.37015959 |
| 31 | Syringomyelia (HP:0003396) | 2.37015959 |
| 32 | Blue sclerae (HP:0000592) | 2.34508426 |
| 33 | Onycholysis (HP:0001806) | 2.31308086 |
| 34 | Soft skin (HP:0000977) | 2.31113937 |
| 35 | Abnormality of oral frenula (HP:0000190) | 2.30325254 |
| 36 | Thick nail (HP:0001805) | 2.29268731 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.25740896 |
| 38 | Peritonitis (HP:0002586) | 2.24366483 |
| 39 | Tetraparesis (HP:0002273) | 2.21238795 |
| 40 | Increased connective tissue (HP:0009025) | 2.19507667 |
| 41 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15585481 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.15334634 |
| 43 | Ridged nail (HP:0001807) | 2.14870556 |
| 44 | Abnormality of the acetabulum (HP:0003170) | 2.11799513 |
| 45 | Orthostatic hypotension (HP:0001278) | 2.09976896 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.04538867 |
| 47 | Abnormality of dentin (HP:0010299) | 2.04173502 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02178289 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.02178289 |
| 50 | Ulnar bowing (HP:0003031) | 2.01933113 |
| 51 | Myocardial infarction (HP:0001658) | 2.00540656 |
| 52 | Slender build (HP:0001533) | 2.00501070 |
| 53 | Upper limb amyotrophy (HP:0009129) | 1.98326444 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 1.98326444 |
| 55 | Cardiovascular calcification (HP:0011915) | 1.98052259 |
| 56 | Flat acetabular roof (HP:0003180) | 1.95798412 |
| 57 | Insomnia (HP:0100785) | 1.95336677 |
| 58 | Absent frontal sinuses (HP:0002688) | 1.93867454 |
| 59 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.92875446 |
| 60 | Natal tooth (HP:0000695) | 1.91276153 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 1.90878597 |
| 62 | Joint laxity (HP:0001388) | 1.89968077 |
| 63 | Cerebral aneurysm (HP:0004944) | 1.88703749 |
| 64 | Dysostosis multiplex (HP:0000943) | 1.88204444 |
| 65 | Generalized amyotrophy (HP:0003700) | 1.87133364 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85541737 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85541737 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85541737 |
| 69 | Mitral valve prolapse (HP:0001634) | 1.85037618 |
| 70 | Vertebral arch anomaly (HP:0008438) | 1.84227135 |
| 71 | Aneurysm (HP:0002617) | 1.83790199 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 1.83754766 |
| 73 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83094711 |
| 74 | Thin bony cortex (HP:0002753) | 1.82327648 |
| 75 | Aortic regurgitation (HP:0001659) | 1.81976104 |
| 76 | Entropion (HP:0000621) | 1.78877102 |
| 77 | Neurofibrillary tangles (HP:0002185) | 1.77633566 |
| 78 | Relative macrocephaly (HP:0004482) | 1.77606411 |
| 79 | Overgrowth (HP:0001548) | 1.77241534 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76497984 |
| 81 | Hyperextensible skin (HP:0000974) | 1.73828837 |
| 82 | Hand muscle atrophy (HP:0009130) | 1.73723020 |
| 83 | Deformed sella turcica (HP:0002681) | 1.70971410 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69619500 |
| 85 | Disproportionate tall stature (HP:0001519) | 1.68181222 |
| 86 | Upper limb muscle weakness (HP:0003484) | 1.67513235 |
| 87 | Broad face (HP:0000283) | 1.66653747 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66427899 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66405324 |
| 90 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.66168016 |
| 91 | Selective tooth agenesis (HP:0001592) | 1.66002394 |
| 92 | Tibial bowing (HP:0002982) | 1.64925423 |
| 93 | Subacute progressive viral hepatitis (HP:0006572) | 1.64614193 |
| 94 | Ovoid vertebral bodies (HP:0003300) | 1.63722307 |
| 95 | Nail dystrophy (HP:0008404) | 1.63395027 |
| 96 | Abnormality of carpal bone ossification (HP:0006257) | 1.62835337 |
| 97 | Abnormal ossification of hand bones (HP:0005921) | 1.62788551 |
| 98 | Periodontitis (HP:0000704) | 1.62693411 |
| 99 | Hyperacusis (HP:0010780) | 1.62511247 |
| 100 | Fragile nails (HP:0001808) | 1.62280944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.33441334 |
| 2 | LATS2 | 3.10763863 |
| 3 | MST1R | 2.79392251 |
| 4 | EPHA2 | 2.66146525 |
| 5 | CDK12 | 2.42967883 |
| 6 | SCYL2 | 2.38008882 |
| 7 | PDGFRA | 2.31154984 |
| 8 | ARAF | 2.18948061 |
| 9 | PRPF4B | 2.03136654 |
| 10 | MOS | 2.02319066 |
| 11 | TRIB3 | 1.99876468 |
| 12 | ERN1 | 1.99491918 |
| 13 | MAP3K3 | 1.84383124 |
| 14 | PTK2 | 1.82629465 |
| 15 | MET | 1.82213998 |
| 16 | PAK4 | 1.80758867 |
| 17 | LATS1 | 1.79311796 |
| 18 | NME2 | 1.75816438 |
| 19 | TRPM7 | 1.68678317 |
| 20 | NEK9 | 1.66153024 |
| 21 | TGFBR2 | 1.60370601 |
| 22 | KSR2 | 1.58488482 |
| 23 | TTN | 1.56422167 |
| 24 | EIF2AK1 | 1.53906528 |
| 25 | MAP2K3 | 1.50927431 |
| 26 | EPHB2 | 1.40843312 |
| 27 | MAP3K2 | 1.40244055 |
| 28 | SIK1 | 1.39806544 |
| 29 | STK10 | 1.38395715 |
| 30 | EPHB1 | 1.37570053 |
| 31 | PIM2 | 1.35403200 |
| 32 | ERBB4 | 1.33223829 |
| 33 | TAOK2 | 1.33128915 |
| 34 | EIF2AK3 | 1.26711965 |
| 35 | KSR1 | 1.26518813 |
| 36 | MAP3K12 | 1.26382723 |
| 37 | DDR2 | 1.24949168 |
| 38 | MAP3K14 | 1.23131462 |
| 39 | BMPR2 | 1.19353021 |
| 40 | ICK | 1.17054940 |
| 41 | RIPK1 | 1.16713878 |
| 42 | MYLK | 1.16507841 |
| 43 | NEK1 | 1.12215291 |
| 44 | RAF1 | 1.08991642 |
| 45 | STK38 | 1.08841395 |
| 46 | TESK1 | 1.05692799 |
| 47 | MAP3K8 | 1.00581004 |
| 48 | STK3 | 0.99476285 |
| 49 | TESK2 | 0.98920941 |
| 50 | MAP3K1 | 0.96711649 |
| 51 | MAP3K13 | 0.95886688 |
| 52 | ERBB3 | 0.95135285 |
| 53 | BRAF | 0.94929669 |
| 54 | PAK2 | 0.92633537 |
| 55 | MAP3K6 | 0.90886802 |
| 56 | ABL2 | 0.89795444 |
| 57 | NTRK1 | 0.89727834 |
| 58 | GRK7 | 0.89108738 |
| 59 | MAP3K9 | 0.88450271 |
| 60 | IRAK4 | 0.87319779 |
| 61 | PDGFRB | 0.86632711 |
| 62 | TBK1 | 0.84073775 |
| 63 | MTOR | 0.80035934 |
| 64 | AKT3 | 0.79140188 |
| 65 | DYRK3 | 0.78102089 |
| 66 | JAK1 | 0.76659410 |
| 67 | FLT3 | 0.67539815 |
| 68 | STK4 | 0.67175995 |
| 69 | SMG1 | 0.64915757 |
| 70 | LRRK2 | 0.64642073 |
| 71 | MAP3K5 | 0.63746067 |
| 72 | JAK3 | 0.62918378 |
| 73 | TAOK1 | 0.62624555 |
| 74 | PKN2 | 0.62102587 |
| 75 | YES1 | 0.61697685 |
| 76 | CLK1 | 0.58728556 |
| 77 | CDK6 | 0.57682200 |
| 78 | TYK2 | 0.56058004 |
| 79 | ZAP70 | 0.54964150 |
| 80 | RPS6KA4 | 0.54720442 |
| 81 | CDK8 | 0.53359096 |
| 82 | STK38L | 0.52962901 |
| 83 | BRD4 | 0.52417379 |
| 84 | FGFR4 | 0.50422770 |
| 85 | CAMK1G | 0.49812738 |
| 86 | BMX | 0.49695505 |
| 87 | CDC42BPA | 0.49408253 |
| 88 | PDPK1 | 0.48707907 |
| 89 | PRKG2 | 0.48352573 |
| 90 | ROCK2 | 0.45937053 |
| 91 | IRAK2 | 0.45623794 |
| 92 | EEF2K | 0.43893419 |
| 93 | MELK | 0.43884477 |
| 94 | CSK | 0.42921014 |
| 95 | ILK | 0.40265844 |
| 96 | FGR | 0.39734584 |
| 97 | STK24 | 0.39424861 |
| 98 | PAK1 | 0.37914856 |
| 99 | CAMK1D | 0.37876685 |
| 100 | MARK3 | 0.36577173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.14936846 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.89417097 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.03603766 |
| 4 | Bladder cancer_Homo sapiens_hsa05219 | 1.97752422 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94850599 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90947255 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 1.79657939 |
| 8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70340106 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.70148133 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69505452 |
| 11 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.67987795 |
| 12 | Shigellosis_Homo sapiens_hsa05131 | 1.63693515 |
| 13 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.61482250 |
| 14 | Thyroid cancer_Homo sapiens_hsa05216 | 1.56801689 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56175682 |
| 16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.54159122 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.50240341 |
| 18 | Amoebiasis_Homo sapiens_hsa05146 | 1.49263341 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.48852732 |
| 20 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.44190710 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.42509977 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35993266 |
| 23 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.33843683 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.33638428 |
| 25 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31421589 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31032474 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30011702 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28054086 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.27147666 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.25333559 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.19799048 |
| 32 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.17573034 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.16745147 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16104289 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15987239 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15093885 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12812658 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.12662175 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.12472251 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10889853 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10175733 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09966819 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.09319929 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08239560 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07444195 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04336748 |
| 47 | Prostate cancer_Homo sapiens_hsa05215 | 1.04145398 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02600670 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.01262478 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99510323 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.99337316 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97006211 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.96171926 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93521057 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93012266 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92544267 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92008038 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88612066 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87781223 |
| 60 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85323837 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84834020 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83756512 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83534408 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82804668 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.82543269 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81472380 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79129171 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78598696 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.76476244 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75184463 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.75134238 |
| 72 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74747035 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73713359 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73460715 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71929971 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71530133 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71424060 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70617069 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68650365 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66845020 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66012361 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64212495 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63691997 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63209851 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63206582 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62377490 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62027987 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61739086 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58851330 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57591106 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57452439 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55631933 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53392609 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53029875 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51155207 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49595190 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48195313 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.47708992 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47356559 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47268783 |

